Therapeutic Plasma Exchange for a Critically Ill Late Preterm Infant with Multisystem Inflammatory Syndrome of Children: A Case Report and Review of the Literature

Adviye Cakil Saglik; Seda Yilmaz Semerci; Erhan Aygun; Hakan Gemici; Neval Topal; Gokhan Buyukkale

doi:10.1055/s-0044-1789607

Journal of Pediatric Infectious Diseases, Inhaltsverzeichnis

J Pediatr Infect Dis 2024; 19(06): 360-364
DOI: 10.1055/s-0044-1789607

Case Report

Therapeutic Plasma Exchange for a Critically Ill Late Preterm Infant with Multisystem Inflammatory Syndrome of Children: A Case Report and Review of the Literature

Adviye Cakil Saglik

¹Department of Neonatology, Istanbul Kanuni Sultan Suleyman Research and Training Hospital, University of Health Sciences, Istanbul, Türkiye

,

Seda Yilmaz Semerci

¹Department of Neonatology, Istanbul Kanuni Sultan Suleyman Research and Training Hospital, University of Health Sciences, Istanbul, Türkiye

,

Erhan Aygun

¹Department of Neonatology, Istanbul Kanuni Sultan Suleyman Research and Training Hospital, University of Health Sciences, Istanbul, Türkiye

,

Hakan Gemici

²Pediatrics, Pediatric Intensive Care Unit Department, Istanbul Kanuni Sultan Suleyman Research and Training Hospital, University of Health Sciences, Istanbul, Türkiye

,

Neval Topal

³Pediatric Emergency Department, Istanbul Kanuni Sultan Suleyman Research and Training Hospital, University of Health Sciences, Istanbul, Türkiye

,

Gokhan Buyukkale

¹Department of Neonatology, Istanbul Kanuni Sultan Suleyman Research and Training Hospital, University of Health Sciences, Istanbul, Türkiye

› Institutsangaben

Abstract

Multisystem inflammatory syndrome of children (MIS-C) is a clinical picture that entered the medical nomenclature after the coronavirus disease 2019 pandemic. Although it primarily affects older children, there have been a limited number of cases reported during the neonatal period. Herein we present a patient, a late preterm infant, with severe MIS-C-related cerebral sinus venous thrombosis who was successfully treated with therapeutic plasma exchange. Practitioners can consider therapeutic plasma exchange as a safe and effective option for the treatment of critically ill MIS-C cases.

Keywords

COVID-19 - MIS-C - newborn - therapeutic plasma exchange

Volltext

Referenzen

References
1 Deng CX. The global battle against SARS-CoV-2 and COVID-19. Int J Biol Sci 2020; 16 (10) 1676-1677
2 Centers for Disease Control and Prevention. Multisystem inflammatory syndrome in children (MIS-C) associated with coronavirus disease 2019 (COVID-19). CDC Health Alert Network; 2020.
3 Melgar M, Lee EH, Miller AD. et al. Council of State and Territorial Epidemiologists/CDC surveillance case definition for multisystem inflammatory syndrome in children associated with SARS-CoV-2 infection - United States. MMWR Recomm Rep 2022; 71 (04) 1-14
4 Centers for Disease Control and Prevention (CDC). CSTE. https://ndc.services.cdc.gov/case-definitions/multisystem-inflammatory-syndrome-in-children-mis-c-2023/
5 More K, Aiyer S, Goti A. et al. Multisystem inflammatory syndrome in neonates (MIS-N) associated with SARS-CoV2 infection: a case series. Eur J Pediatr 2022; 181 (05) 1883-1898
6 Zuccotti G, Calcaterra V, Mannarino S. et al. Six-month multidisciplinary follow-up in multisystem inflammatory syndrome in children: an Italian single-center experience. Front Pediatr 2023; 10: 1080654
7 De Rose DU, Pugnaloni F, Calì M. et al. Multisystem inflammatory syndrome in neonates born to mothers with SARS-CoV-2 infection (MIS-N) and in neonates and infants younger than 6 months with acquired COVID-19 (MIS-C): a systematic review. Viruses 2022; 14 (04) 750
8 Jiang L, Tang K, Levin M. et al. COVID-19 and multisystem inflammatory syndrome in children and adolescents. Lancet Infect Dis 2020; 20 (11) e276-e288
9 Mascarenhas D, Goyal M, Haribalakrishna A, Nanavati R, Ish P, Kunal S. Multisystem inflammatory syndrome in neonates (MIS-N): a systematic review. Eur J Pediatr 2023; 182 (05) 2283-2298
10 Pawar R, Gavade V, Patil N. et al. Neonatal multisystem inflammatory syndrome (MIS-N) associated with prenatal maternal SARS-CoV-2: a case series. Children (Basel) 2021; 8 (07) 572
11 Sözeri B, Çağlayan Ş, Atasayan V. et al. The clinical course and short-term health outcomes of multisystem inflammatory syndrome in children in the single pediatric rheumatology center. Postgrad Med 2021; 133 (08) 994-1000
12 Porosnicu TM, Sirbu IO, Oancea C. et al. The impact of therapeutic plasma exchange on inflammatory markers and acute phase reactants in patients with severe SARS-CoV-2 infection. Medicina (Kaunas) 2023; 59 (05) 867
13 Ebermeyer T, Hequet O, Berard F. et al. The efficacy of therapeutic plasma exchange in COVID-19 patients on endothelial tightness in vitro is hindered by platelet activation. Front Cardiovasc Med 2023; 10: 1094786
14 Durak C, Guney Sahin E, Can YY, Varol F. Retrospective evaluation of therapeutic plasma exchange treatment in a pediatric intensive care unit: single-center experience. Artif Organs 2023; 47 (09) 1464-1471
15 Al-Hashami S, Khamis F, Al-Yahyay M. et al. Therapeutic plasma exchange: a potential therapeutic modality for critically ill adults with severe acute respiratory syndrome coronavirus 2 infection. J Clin Apher 2022; 37 (06) 563-572
16 Atay G, Hasbal C, Türk M, Erdoğan S, Sözeri B. The role of therapeutic plasma exchange (TPE) in multisystem inflammatory syndrome in children (MIS-C). Children (Basel) 2021; 8 (06) 498
17 Katlan B, Kesici S, Karacanoğlu D. et al. Early is superior to late plasma exchange for severe multisystem inflammatory syndrome in children. J Clin Apher 2022; 37 (03) 281-291
18 Dakay K, Cooper J, Bloomfield J. et al. Cerebral venous sinus thrombosis in COVID-19 infection: a case series and review of the literature. J Stroke Cerebrovasc Dis 2021; 30 (01) 105434
19 Lindan CE, Mankad K, Ram D. et al; ASPNR PECOBIG Collaborator Group. Neuroimaging manifestations in children with SARS-CoV-2 infection: a multinational, multicentre collaborative study. Lancet Child Adolesc Health 2021; 5 (03) 167-177
20 Trapani S, Rubino C, Lasagni D. et al. Thromboembolic complications in children with COVID-19 and MIS-C: a narrative review. Front Pediatr 2022; 10: 944743
21 Whitworth H, Sartain SE, Kumar R. et al. Rate of thrombosis in children and adolescents hospitalized with COVID-19 or MIS-C. Blood 2021; 138 (02) 190-198
22 Davies P, Evans C, Kanthimathinathan HK. et al. Intensive care admissions of children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS) in the UK: a multicentre observational study. Lancet Child Adolesc Health 2020; 4 (09) 669-677
23 Aguilera-Alonso D, Murias S, Martínez-de-Azagra Garde A. et al; EPICO-AEP Working Group. Prevalence of thrombotic complications in children with SARS-CoV-2. Arch Dis Child 2021; 106 (11) 1129-1132
24 Di Profio E, Leone A, Vizzuso S. et al. Longitudinal anthropometry and body composition in children with SARS-CoV-2-associated multisystem inflammatory syndrome. J Pediatr Gastroenterol Nutr 2023; 76 (04) 505-511
25 National Institutes of Health (NIH). Treatment considerations for children with MIS-C. Accessed February 29, 2024 at: https://www.covid19treatmentguidelines.nih.gov/management/clinical-management-of-children/hospitalized-children-therapeutic-management-of-mis-c/